IL158868A0 - Methods of generating and using stem cells enriched with immature primitive progenitor - Google Patents

Methods of generating and using stem cells enriched with immature primitive progenitor

Info

Publication number
IL158868A0
IL158868A0 IL15886803A IL15886803A IL158868A0 IL 158868 A0 IL158868 A0 IL 158868A0 IL 15886803 A IL15886803 A IL 15886803A IL 15886803 A IL15886803 A IL 15886803A IL 158868 A0 IL158868 A0 IL 158868A0
Authority
IL
Israel
Prior art keywords
generating
methods
stem cells
cells enriched
primitive progenitor
Prior art date
Application number
IL15886803A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL15886803A priority Critical patent/IL158868A0/xx
Publication of IL158868A0 publication Critical patent/IL158868A0/xx
Priority to JP2006539071A priority patent/JP2007511219A/ja
Priority to AU2004288879A priority patent/AU2004288879B2/en
Priority to PCT/IL2004/001018 priority patent/WO2005047494A2/en
Priority to ES04799327.4T priority patent/ES2534724T3/es
Priority to US10/578,291 priority patent/US20080025957A1/en
Priority to EP04799327.4A priority patent/EP1682653B1/en
Priority to CA002545409A priority patent/CA2545409A1/en
Priority to IL175430A priority patent/IL175430A/en
Priority to NO20062709A priority patent/NO335515B1/no
Priority to US13/031,466 priority patent/US8367057B2/en
Priority to JP2012032163A priority patent/JP5547221B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/21—Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
IL15886803A 2003-11-13 2003-11-13 Methods of generating and using stem cells enriched with immature primitive progenitor IL158868A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL15886803A IL158868A0 (en) 2003-11-13 2003-11-13 Methods of generating and using stem cells enriched with immature primitive progenitor
CA002545409A CA2545409A1 (en) 2003-11-13 2004-11-08 Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
ES04799327.4T ES2534724T3 (es) 2003-11-13 2004-11-08 Células madre hematopoyéticas adecuadas para el trasplante, su preparación y composiciones farmacéuticas que las comprenden
AU2004288879A AU2004288879B2 (en) 2003-11-13 2004-11-08 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
PCT/IL2004/001018 WO2005047494A2 (en) 2003-11-13 2004-11-08 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
JP2006539071A JP2007511219A (ja) 2003-11-13 2004-11-08 移植に好適な幹細胞、その調製およびそれらを含む医薬組成物
US10/578,291 US20080025957A1 (en) 2003-11-13 2004-11-08 Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them
EP04799327.4A EP1682653B1 (en) 2003-11-13 2004-11-08 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
IL175430A IL175430A (en) 2003-11-13 2006-05-04 A method for the preparation, use and use of stem cell ulceration
NO20062709A NO335515B1 (no) 2003-11-13 2006-06-12 In vitro fremgangsmåte for fremstilling av en populasjon av celler som omfatter hematopoetiske stamceller, cellepopulasjon, anvendelse derav og farmasøytisk preparat omfattende nevnte cellepopulasjon.
US13/031,466 US8367057B2 (en) 2003-11-13 2011-02-21 Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
JP2012032163A JP5547221B2 (ja) 2003-11-13 2012-02-16 移植に好適な幹細胞、その調製およびそれらを含む医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15886803A IL158868A0 (en) 2003-11-13 2003-11-13 Methods of generating and using stem cells enriched with immature primitive progenitor

Publications (1)

Publication Number Publication Date
IL158868A0 true IL158868A0 (en) 2004-05-12

Family

ID=34044273

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15886803A IL158868A0 (en) 2003-11-13 2003-11-13 Methods of generating and using stem cells enriched with immature primitive progenitor
IL175430A IL175430A (en) 2003-11-13 2006-05-04 A method for the preparation, use and use of stem cell ulceration

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL175430A IL175430A (en) 2003-11-13 2006-05-04 A method for the preparation, use and use of stem cell ulceration

Country Status (9)

Country Link
US (2) US20080025957A1 (https=)
EP (1) EP1682653B1 (https=)
JP (2) JP2007511219A (https=)
AU (1) AU2004288879B2 (https=)
CA (1) CA2545409A1 (https=)
ES (1) ES2534724T3 (https=)
IL (2) IL158868A0 (https=)
NO (1) NO335515B1 (https=)
WO (1) WO2005047494A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121719A1 (en) 2007-03-30 2008-10-09 The Cleveland Clinic Foundation Method of treating ischemic disorders
US20050271639A1 (en) * 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
RU2425876C2 (ru) 2006-03-24 2011-08-10 Чилдрен'З Медикал Сентер Корпорейшн Способ модулирования роста гематопоэтических стволовых клеток
EP3824885A1 (en) 2006-10-20 2021-05-26 Children's Medical Center Corporation Method to enhance tissue regeneration
EP2094839B1 (en) 2006-12-08 2020-02-05 University of Rochester Expansion of hematopoietic stem cells
US8198083B1 (en) 2007-10-31 2012-06-12 William Gunter Loudon Organotypic slices of the central nervous system
CA2709398C (en) 2007-12-14 2017-11-07 The Cleveland Clinic Foundation Use of stromal cell-derived factor 1 for promoting wound healing
CN108379292A (zh) 2008-11-06 2018-08-10 印第安纳大学研究与技术公司 增强造血干细胞植入过程的材料和方法
WO2011026041A2 (en) 2009-08-28 2011-03-03 The Cleveland Clinic Foundation Sdf-1 delivery for treating ischemic tissue
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
ES2769270T3 (es) 2011-09-30 2020-06-25 Bluebird Bio Inc Compuestos para transducción viral mejorada
JP6220791B2 (ja) * 2011-12-02 2017-10-25 フェイト セラピューティクス，インコーポレイテッド 増強された幹細胞組成物
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
IL261002B2 (en) 2016-02-12 2024-07-01 Bluebird Bio Inc Vcn enhancer compositions and methods of using the same
WO2017139561A1 (en) 2016-02-12 2017-08-17 Bluebird Bio, Inc. Vcn enhancer compositions and methods of using the same
GB201807944D0 (en) * 2018-05-16 2018-06-27 Ospedale San Raffaele Srl Compositions and methods for haematopoietic stem cell transplantation
GB201900702D0 (en) 2019-01-18 2019-03-06 Univ Bristol Therapy
JP2023541168A (ja) * 2020-09-14 2023-09-28 ジェネロス カンパニー， リミテッド 改良された生着可能性を有する幹細胞を調製するための方法
WO2023010068A2 (en) * 2021-07-28 2023-02-02 Cartesian Therapeutics, Inc. Multiprotein-engineered cells secreting a multispecific antibody

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
DE122007000007I2 (de) 1986-04-09 2010-12-30 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DE69010526T2 (de) * 1989-02-06 1994-12-08 Mitsubishi Petrochemical Co Verfahren zur Herstellung von L-Alanin.
US6326198B1 (en) * 1990-06-14 2001-12-04 Regents Of The University Of Michigan Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6447766B1 (en) * 1993-06-08 2002-09-10 Smithkline Beecham Corporation Method of mobilizing hematopoietic stem cells
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6143292A (en) * 1995-05-25 2000-11-07 Baxter International Inc. Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
US5928638A (en) * 1996-06-17 1999-07-27 Systemix, Inc. Methods for gene transfer
US6090622A (en) * 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6511958B1 (en) * 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
ATE357509T1 (de) * 1997-09-29 2007-04-15 Point Therapeutics Inc Stimulierung von hämatopoietischen zellen im vitro
US6132708A (en) * 1997-10-10 2000-10-17 Oregon Health Sciences University Liver regeneration using pancreas cells
US6248587B1 (en) * 1997-11-26 2001-06-19 University Of Southern Cailfornia Method for promoting mesenchymal stem and lineage-specific cell proliferation
WO1999048524A1 (en) * 1998-03-03 1999-09-30 University Of Southern California Use of cytokines and mitogens to inhibit graft versus host disease
US6383481B1 (en) * 1998-03-30 2002-05-07 Japan Immunoresearch Laboratories Co., Ltd. Method for transplantation of hemopoietic stem cells
US6184035B1 (en) * 1998-11-18 2001-02-06 California Institute Of Technology Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
US6280718B1 (en) * 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
US6436704B1 (en) * 2000-04-10 2002-08-20 Raven Biotechnologies, Inc. Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
DK1411918T3 (da) * 2001-07-31 2012-04-23 Genzyme Global S A R L Fremgangsmåder til at mobilisere progenitor/stamceller
IL146970A0 (en) * 2001-12-06 2002-08-14 Yeda Res & Dev Migration of haematopoietic stem cells and progenitor cells to the liver
EP1461087A1 (en) 2001-12-06 2004-09-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders

Also Published As

Publication number Publication date
IL175430A0 (en) 2006-09-05
EP1682653B1 (en) 2015-03-25
WO2005047494A3 (en) 2005-06-23
US20080025957A1 (en) 2008-01-31
JP2007511219A (ja) 2007-05-10
NO335515B1 (no) 2014-12-22
JP2012125249A (ja) 2012-07-05
IL175430A (en) 2015-01-29
AU2004288879A1 (en) 2005-05-26
AU2004288879B2 (en) 2011-06-16
CA2545409A1 (en) 2005-05-26
US20110268712A1 (en) 2011-11-03
JP5547221B2 (ja) 2014-07-09
NO20062709L (no) 2006-08-11
EP1682653A2 (en) 2006-07-26
US8367057B2 (en) 2013-02-05
ES2534724T3 (es) 2015-04-27
WO2005047494A2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
IL158868A0 (en) Methods of generating and using stem cells enriched with immature primitive progenitor
IL167832A (en) Sesquiterpene synthases and methods of use
AU2003295444A8 (en) Methods for in vitro expansion of hematopoietic stem cells
GB2406523B (en) Improvements in and relating to the formation of knots
PL1824566T3 (pl) Kompozycje doustne zawierające ekstrakt z rozmarynu i związane sposoby
EP1668109A4 (en) HEMATOPOETIC STEM CELLS TREATED WITH IN VITRO FUCOSYLATION AND METHOD OF USE
PL372619A1 (en) Primitive and proximal hepatic stem cells
IL164181A0 (en) Anti-il-tif antibodies and methods of using in inflammation
AU2003241313A8 (en) Compositions and methods for stem cell delivery
GB2389410B (en) Lighter and method of use
PT1542714E (pt) Métodos para aumentar a produção de células estaminais plaquetárias e hematopoiéticas
IL200207A0 (en) Stem cells having increased sensitivity to a chemo-attractant and methods of generating and using same
IL217561A0 (en) Use of cytokininis to increase the ratio of wild type to mutant protein in cells
AU2003287521A8 (en) Pluripotent cells from monocytes, and methods of making and using pluripotent cells
ZA200710554B (en) Expression vector and methods of producing high levels of proteins
CA104143S (en) Brush
GB0216818D0 (en) Generating animation with constrained parameters
IL146970A0 (en) Migration of haematopoietic stem cells and progenitor cells to the liver
GB0222328D0 (en) Improvements in and relating to the control of instruments
ZA200705093B (en) Oral compositions containing extracts of rosmarinus and related methods
EP1571947A4 (en) CONVERTIBLE TOY BETWEEN A CHAIR AND A HAIRDRESSER
EP1633337A4 (en) METHODS OF USING NITROXIDES IN CONJUNCTION WITH PHOTOSENSITIZERS AND SENOSENSITIZERS
AU158174S (en) Toothbrush
AU2003241661A1 (en) Photosensitizer for generating singlet oxygen and method for generating singlet oxygen
IL164507A0 (en) Enhancement of hematopoietic stem cell survival